Close

Wedbush Recommends Buying Sangamo BioSciences (SGMO) on Weakness

August 6, 2015 1:07 PM EDT Send to a Friend
Wedbush analyst Liana Moussatos is out defending Sangamo BioSciences (NASDAQ: SGMO) mid-day with shares getting sliced to the tune of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login